Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.
One Driver Arrested of Two Hit and Runs
Unifor and GM reach tentative contract agreement
Marineland ships another three belugas to San Diego
PM Carney says Canada will Meet U.S tariffs “Dollar for Dollar”
Province Investing in Niagara Businesses
Stolen Bikes/ATV Suspects Arrested
Mayor Frustrated at 'Bureaucratic Process'
WSIB Offices Closing, Including St. Catharines